Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified LMB-89 for Pediatric B-Cell NHL and B-ALL
NCT00187161Phase 2Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Nov 1994
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, vincristine, prednisone, doxorubicin, methotrexate in Burkitt lymphoma (BL), diffuse large B-cell lymphoma (DLBCL), B cell acute lymphoblastic leukemia (B-ALL), sponsored by St. Jude Children's Research Hospital. Started Nov 1994; status: completed.
02
Drugs
cyclophosphamidevincristineprednisonedoxorubicinmethotrexate
03
Conditions
Burkitt lymphoma (BL)diffuse large B-cell lymphoma (DLBCL)B cell acute lymphoblastic leukemia (B-ALL)
Beyond the preview
Go deeper on NCT00187161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00187161.